Moderna (MRNA) Tops Q4 EPS by 5c

Coronavirus Stocks Surge on Increasingly Likely Pandemic

February 25, 2020 3:35 PM EST

Coronavirus stocks continue to soar as officials now see an increasingly likely pandemic.

Coronavirus stocks

Alpha Pro Tech Ltd. (NYSE: APT) +50%Moderna (NASDAQ: MRNA) +32%Lakeland Industries (NASDAQ: LAKE) +6%Co-Diagnostics (NASDAQ: CODX) +9.5%... More

Availability of Vaccines Could be Year to Year and Half - HHS

February 25, 2020 3:07 PM EST

(Updated - February 25, 2020 3:18 PM EST)

(Updated - February 25, 2020 3:17 PM EST)

Community Spread of Coronavirus in Other Countries Outside China Very Concerning - HHS

Intimidate Risk in U.S. is Low, Must Continue to PrepareVaccine Development on Time, in Human Trial in Month and... More

Moderna (MRNA) Extends Gain, Up 30%

February 25, 2020 2:47 PM EST

Moderna (NASDAQ: MRNA) Extends Gain, Up 30%

... More

Pre-Open Stock Movers 2/25: (MNK) (LL) (MRNA) Higher (TUP) (PANW) (SHAK) Lower (more...)

February 25, 2020 9:21 AM EST

Today's Pre-Open Stock Movers

Mallinckrodt Plc (NYSE: MNK) 38.2% HIGHER; its specialty generic unit will file for bankruptcy protection as it agreed to settle opioid-related cases globally by paying $1.6 billion over eight years.

Tupperware Brands (NYSE: TUP)... More

Moderna (MRNA) Reports First Shipment of mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study

February 25, 2020 5:51 AM EST

Moderna, Inc., (NASDAQ: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients today announced that it has released the first batch of mRNA-1273, the Companys vaccine against the novel coronavirus, for human use. Vials of mRNA-1273 have been shipped to the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) to be used in the planned Phase 1 study in the U.S.

mRNA-1273 is an mRNA vaccine against the novel... More

Moderna (MRNA) calls active into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study

February 25, 2020 5:15 AM EST

Moderna (NASDAQ: MRNA) 30 option implied volatility is at 87; compared to its 52-week range of 51 to 99 into disclosing shipment of mRNA vaccine for Phase 1 coronavirus study. Call put ratio 6 calls to 1 put.

... More

After-Hours Stock Movers 02/24: (MRNA) (MMSI) (NLS) Higher; (PANW) (EVER) (SHAK) Lower (more...)

February 24, 2020 5:57 PM EST

Today's After-Hours Stock Movers

Moderna (NASDAQ: MRNA) 14.7% HIGHER; shipped the first batch of its coronavirus vaccine to U.S. government researchers who will launch the first human tests, according to Dow Jones.

Palo Alto Networks (NYSE: PANW) 14.2% LOWER; reported Q2 EPS of $1.19, $0.07 better than the analyst estimate of $1.12. Revenue for the quarter came in at $816.7 million versus the consensus estimate of $843.26 million. Palo Alto Networks sees Q3 2020 EPS of $0.96-$0.98, versus the consensus of $1.25. Palo Alto Networks... More

Moderna (MRNA) Surges 15% After Shipping First Batch of Coronavirus Vaccine for Testing

February 24, 2020 5:34 PM EST

Moderna (NASDAQ: MRNA) gains 15% after-hours following reports from Dow Jones the company shipped the first batch of its coronavirus vaccine to U.S. government researchers who will launch the first human tests.

... More

Moderna (MRNA) Delivers First Coronavirus Vaccine for Human Testing - DJ

February 24, 2020 4:46 PM EST

Moderna (NASDAQ: MRNA) shipped the first batch of its coronavirus vaccine to U.S. government researchers who will launch the first human tests, according to Dow Jones.

... More